FDA•
Proin ER Tablets
Pegasus recalls Proin ER 145mg tablets for dogs due to failed dissolution specs.
Filters
Category
Agency
Severity
Date
Distributed in
Drugs Recalls
Back to home ←
FDA•Ascend Laboratories: Multiple Dabigatran Etexilate CapsulesAscend recalls Dabigatran Etexilate Capsules (150 mg, 75 mg) over impurity/degradation failures.
3 products
FDA•Mycophenolate Mofetil for InjectionMylan recalls Mycophenolate Mofetil for Injection 500 mg vials due to precipitate.
FDA•Glycopyrrolate Oral SolutionPrecision Dose recalls Glycopyrrolate Oral Solution over an unidentified impurity.
FDA•Cetirizine Hydrochloride Tablets 5 mgRising Pharma recalls Cetirizine HCl 5 mg tablets over Ranitidine cross-contamination.
FDA•Trokendi XR 25mg CapsulesSupernus Pharmaceuticals is recalling Trokendi XR 25mg capsules due to failed dissolution specifications.
- FDA•Ascend Laboratories: Multiple Dabigatran Etexilate Capsules
Ascend Laboratories is recalling 110 mg and 150 mg Dabigatran etexilate capsules due to failed impurity and degradation specifications.
2 products 
FDA•Divalproex Sodium Delayed-Release TabletsBionpharma is recalling 500 mg Divalproex Sodium Delayed-Release Tablets due to the presence of foreign tablets or capsules in the bottles.
FDA•CRITICALDiclofenac Sodium 0.1% Eye OintmentMFV Compounding Pharmacy is recalling Diclofenac Sodium 0.1% Eye Ointment due to potential Bacillus cereus contamination.
FDA•CRITICALBeekeeper's Naturals Saline Nasal SprayBeekeeper's Naturals is recalling 1 FL OZ Saline Nasal Spray bottles due to potential microbial contamination.
2 products
FDA•CRITICALCareFusion 213: Multiple Chlorhexidine Gluconate ProductsCareFusion recalls BD ChloraPrep Clear and FREPP Clear applicators over sterility concerns from lidding wrinkles.
4 products
FDA•CRITICALDoxorubicin Hydrochloride Liposome InjectionNorthstar Rx is recalling Doxorubicin Hydrochloride Liposome injection 50 mg/25 mL vials due to potential glass particulate contamination.
FDA•CRITICALHaleon US: multiple drugsHaleon is recalling Gas-X Extra Strength softgels in 72-count and 120-count packages due to potential chemical contamination.
2 products
FDA•CRITICALMG217 Multi-Symptom Treatment CreamWisconsin Pharmacal is recalling MG217 Multi-Symptom Treatment Cream due to Staphylococcus aureus contamination.